BOULDER, Colo., Dec. 6, 2024 /PRNewswire/ — Fresh Tracks Therapeutics, Inc. (OTC Pink: FRTX) (“Fresh Tracks” or “the Company”) announced today that a Scheduling Order has been issued by the Court of Chancery of the State of Delaware (“the Court”) setting a hearing date of January 17,…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
